Pulmonx Corporation ROA 2019-2024 | LUNG
Current and historical return on assets (ROA) values for Pulmonx Corporation (LUNG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Pulmonx Corporation ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $-0.06B | $0.17B | -33.38% |
| 2024-06-30 | $-0.06B | $0.17B | -33.10% |
| 2024-03-31 | $-0.06B | $0.17B | -32.73% |
| 2023-12-31 | $-0.06B | $0.18B | -32.23% |
| 2023-09-30 | $-0.06B | $0.19B | -31.57% |
| 2023-06-30 | $-0.06B | $0.19B | -30.38% |
| 2023-03-31 | $-0.06B | $0.20B | -29.14% |
| 2022-12-31 | $-0.06B | $0.19B | -28.37% |
| 2022-09-30 | $-0.06B | $0.20B | -26.58% |
| 2022-06-30 | $-0.05B | $0.21B | -23.53% |
| 2022-03-31 | $-0.05B | $0.22B | -21.80% |
| 2021-12-31 | $-0.05B | $0.24B | -19.88% |
| 2021-09-30 | $-0.05B | $0.25B | -17.73% |
| 2021-06-30 | $-0.04B | $0.25B | -18.59% |
| 2021-03-31 | $-0.04B | $0.26B | -25.76% |
| 2020-12-31 | $-0.03B | $0.26B | -38.21% |
| 2020-06-30 | $-0.02B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||